U.S. senators grill pharmaceutical CEOs on high prescription drug prices
Tuesday, February 26, 2019 - 14:10
in Mathematics & Economics
Both Republican and Democratic senators are challenging one of the most powerful lobbying interests in Washington, as pharmaceutical giants publicly answer questions about their pricing practices.